Adverse reactions to taxanes in breast cancer patients undergoing antineoplastic treatment
DOI:
https://doi.org/10.35381/s.v.v10i1.5029Keywords:
Breast cancer, adverse reactions, chemotherapy, quality of life, taxanes, (Source: DeCS).Abstract
Objective: To identify adverse reactions to taxanes in adult patients with breast cancer undergoing antineoplastic treatment. Method: Qualitative, descriptive, and applied research based on a literature review of articles indexed in recognized databases, published in recent years, analyzed using a hermeneutic approach. Results: Side effects such as depression, alopecia, peripheral neuropathy, cognitive impairment, cardiotoxicity, and ophthalmological and urological disorders were reported. These adverse events, although some are temporary, have a significant impact on quality of life and can compromise the physical and emotional functioning of patients. Conclusions: Taxanes are effective in reducing breast cancer mortality, but they generate significant adverse reactions; their identification and timely management by healthcare personnel is essential to minimize risks and improve comprehensive care.
Downloads
References
Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F. Global burden of cancer in 2008: a systematic analysis of disability- adjusted life-years in 12 world regions. The Lancet. 2012;380(9856):1840-1850. https://doi.org/10.1016/S0140-6736(12)60919-2
Di Sibio A, Abriata G, Forman D, Sierra M. (2016). Female breast cancer in Central and South America. Cancer Epidemiology. 2016;44(1):S110-S120. https://doi.org/10.1016/j.canep.2016.08.010
Corral F, Cueva, Yépez J, Tarupi, M. (2018). Tendencias en la incidencia y mortalidad por cáncer durante tres décadas en Quito-Ecuador. Colomb Med. 2018; 49(1):35-41. http://dx.doi.org/10.25100/cm.v49i1.3785
Núñez-González S, Calle-Celi D, Pilco J, Simancas-Racines D. Cambios en la tendencia temporal de mortalidad por cáncer de mama en Ecuador 2001-2016. REMCB. 2018;39(2). https://doi.org/10.26807/remcb.v39i2.654
Ramos Águila YC, Marimón Torres ER, Crespo González C, Junco Sena B, Valiente Morejón W. Cáncer de mama, su caracterización epidemiológica. Rev Ciencias Médicas. 2015;19(4):619-629. https://n9.cl/nqrkr
Galvis López MA. "Soy una sobreviviente". Experiencias y significados para una mujer con patología oncológica sometida a mastectomía. Index Enferm. 2019;28(1-2):74-78. https://n9.cl/6h4i0
Bender CM, Merriman JD, Gentry AL, Ahrendt, G.M., Berga, S.L., Brufsky, A.M., Casillo, F.E., Dailey, M.M., Erickson, K.I., Kratofil, F.M., McAuliffe, P.F., Rosenzweig, M.Q., Ryan, C.M. and Sereika, S.M. Patterns of change in cognitive function with anastrozole therapy. Cancer. 2015;121(15):2627-2636. https://doi.org/10.1002/cncr.29393
Díaz-Granda MJ, Garrido-Hermosilla AM. Edema macular cistoide bilateral por taxanos en paciente con cáncer de mama. Rev Mex Oftal. 2020;94(5S):243-244. https://n9.cl/u98487
Soran, O. (). Onco-Cardiology for Breast Cancer. En: Aydiner, A., Igci, A., Soran, A. (eds) Breast Disease. Cham Springer. 2019;757-779. https://doi.org/10.1007/978-3-030-16792-9_49
Rimoldi, M. Onicopatía secundaria a capecitabina y taxanos. Dermatol Tev Mex. 2021;65(3):440-443. https://doi.org/10.24245/dermatolrevmex.v65i3.5789
Mejía-Rojas ME, Contreras-Rengifo A, Hernández-Carrillo M. Calidad de vida en mujeres con cáncer de mama sometidas a quimioterapia en Cali, Colombia. Biomed. 2020;40(2):349-361. https://doi.org/10.7705/biomedica.4971
Slaught C, Roman M, Yashar S, Holland V, Goh C. (2021). Permanent Alopecia in Breast Cancer Patients: Role of Taxanes and Endocrine Therapies. Cutis. 2021;107(3):E17-E22. https://doi.org/10.12788/cutis.0215
Danbee K, Im‐Ryung K, Eun‐Kyung C, Young HI, Yeon HP, Jin SA, Jeong EL, Seok JN, Hae KL, Ji‐Hye P, Dong‐Youn L, Mario EL, Eliseo G, Juhee C, Permanent Chemotherapy‐Induced Alopecia in Patients with Breast Cancer: A 3‐Year Prospective Cohort Study. The oncologist. 2019;24(3):414-420. http://dx.doi.org/10.1634/theoncologist.2018-0184
Van Haren F, Van den Heuvel S, Ligtenberg M, Vissers K, Steegers M. Diagnostic tools should be used for the diagnosis of chemotherapy induced peripheral neuropathy in breast cancer patients receiving taxanes. Cancer Reports. 2022;5(10):e1577. https://doi.org/10.1002/cnr2.1577
Folorunso SA, Abiodun OO, Abdus-Salam AA, Wuraola FO. Evaluation of side effects and compliance to chemotherapy in breast cancer patients at a Nigerian tertiary hospital. Ecancermedicalscience. 2023;17:1537. https://doi.org/10.3332/ecancer.2023.1537
Ibrahim EY, Domenicano I, Nyhan K, Elfil M, Mougalian SS, Cartmel B, Ehrlich BA. Cognitive effects and depression associated with taxane-based chemotherapy in breast cancer survivors: a meta-analysis. Front Oncol. 2021;11:642382. https://doi.org/10.3389/fonc.2021.642382
Lv D, Lan B, Zhang L, Sun X, Yang M, Ma F. Association Between Depression and Anxiety Status of Breast Cancer Patients Undergoing Adjuvant Chemotherapy and Chemotherapy-induced Adverse Events. Cancer Med. 2023;12(4):4794-4800. https://doi.org/10.21203/rs.3.rs-1186049/v1
Bonilla-Santos J, González-Montealegre RA, González-Hernández A. An Overview of Psychological Interventions on Breast Cancer Patients: Systematic Review of Randomized Controlled Trials. Salud Uninorte. 2022;38(1):278-298. https://doi.org/10.14482/sun.38.1.616.89
Fontes KP, Veiga DF, Naldoni AC, Sabino-Neto M, Ferreira LM. Physical activity, functional ability, and quality of life after breast cancer surgery. J Plast Reconstr Aesthet Surg. 2019;72(3):394-400. https://doi.org/10.1016/j.bjps.2018.10.029
Bland KA, Kirkham AA, Bovard J, Shenkier T, Zucker D, McKenzie DC, Davis MK, Gelmon KA, Campbell KL. Effect of Exercise on Taxane Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Randomized Controlled Trial. Clin Breast Cancer. 2019;19(6):411-422. https://doi.org/10.1016/j.clbc.2019.05.013
Andersen Hammond E, Pitz M, Steinfeld K, Lambert P, Shay B. An Exploratory Randomized Trial of Physical Therapy for the Treatment of Chemotherapy-Induced Peripheral Neuropathy. Neurorehabil Neural Repair. 2020;34(3):235-246. https://doi.org/10.1177/1545968319899918
Veronese N, Stubbs B, Volpato S, Zuliani G, Maggi S, Cesari M, Lipnicki DM, Smith L, Schofield P, Firth J, Vancampfort D, Koyanagi A, Pilotto A, Cereda E. Association Between Gait Speed With Mortality, Cardiovascular Disease and Cancer: A Systematic Review and Meta-analysis of Prospective Cohort Studies. J Am Med Dir Assoc. 2018;19(11):981-988.e7. https://doi.org/10.1016/j.jamda.2018.06.007
Mase T, Honda S, Yamano M, Kawasaki T. A Case of Docetaxel- Induced Left Ventricular Outflow Tract Obstruction. Cureus. 2023;15(8):e43598. https://doi.org/10.7759/cureus.43598
Ye YT, Zhou ZY, Wen LS, Sun Y, Chu ZJ, Dou GR. The Significance of the Ocular Adverse Effect Induced by Systemic Taxane Application. Front Biosci (Landmark Ed). 2022;27(6):171. https://doi.org/10.31083/j.fbl2706171
Sodhi M, Yeung SN, Maberley D, Mikelberg F, Etminan M. Risk of Ocular Adverse Events With Taxane-Based Chemotherapy. JAMA Ophthalmol. 2022;140(9):880-884. https://doi.org/10.1001/jamaophthalmol.2022.3026
Zaheed M, Wilcken N, Willson ML, O'Connell DL, Goodwin A. Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer. Cochrane Database Syst Rev. 2019;2(2):CD012873. https://doi.org/10.1002/14651858.CD012873
Kırca K, Kutlutürkan S. Symptoms of patients with head and neck cancers undergoing radiotherapy. Eur J Cancer Care. 2017;26(6):e12584. https://doi.org/10.1111/ecc.12584
Willson ML, Burke L, Ferguson T, Ghersi D, Nowak AK, Wilcken N. Taxanes for adjuvant treatment of early breast cancer. Cochrane Database Syst Rev. 2019;9(9):CD004421. https://doi.org/10.1002/14651858.CD004421.pub3
Costa MSCR, Fernandes MR, Pereira EEB, Leal DFDVB, Coelho RCC, Menezes EDS, Modesto AAC, Assumpção PP, Burbano RMR, Santos SEBD, Santos NPCD. Breast Cancer: Clinical-Epidemiological Profile and Toxicities of Women Receiving Treatment with Taxanes in the Amazon Region. J Pers Med. 2023;13(10):1458. https://doi.org/10.3390/jpm13101458
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Abrahan Giuseppe Hernández-Lema, Lupita Melania Armijos-Campoverde, Ariel José Romero-Fernandez
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.
